Proliferation kinetics of bronchiolo-alveolar tumorlets;PROLIFERATIONSKINETIK BRONCHIOLO-ALVEOLARER TUMORLETS

Pathologe

Volumn 17, Issue 2, 1996, Pages 163-170

  Theile, A ^a,b   Muller K M ^b  

^a INSTITUT FÜR PATHOLOGIE   (Germany)

^b NONE

Author keywords

Activity of proliferation; Bronchiolo alveolar tumorlets; Interstitial lung disease; Peripheral lung tumors; Preneoplasias

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ARTICLE; BRONCHUS MUCOSA; CELL PROLIFERATION; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METAPLASIA; PRECANCER; CANCER STEM CELL; CELL DIVISION; CELL TRANSFORMATION; ENZYME IMMUNOASSAY; LUNG ALVEOLUS; LUNG ALVEOLUS CELL CARCINOMA; LUNG FIBROSIS; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; PRECANCEROUS CONDITIONS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0029893394     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050152     Document Type: Article

References (55)

1. Aherne WA, Camplejohn R, Wright NA (eds) (1977) An introduction to cell population kinetics. Edward Arnold, London
2. Auerbach O, Stout AP, Hammond EC, Garfinkel L (1961) Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 265: 253-267
3. Baserga R (1991) Growth regulation on the PCNA agene. J Cell Sci 98: 433-436
4. Bookman AAM, Urowith MB, Mitchell RI (1974) Alveolar-cell carcinoma in progressive systemic scleroderma. J Rheumatol 1: 466-472
5. Bravo R, McDonald-Bravo H (1985) Changes in nuclear distribution of cyclin (PCNA) but not its synthesis depend upon DNA replication. EMBO J 4: 655-661
6. Bruno S, Darzynkiewicz Z (1992) Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-cells. Cell proli 25: 31-40
7. Cattoretti G, Becker MHG, Duchrow M, Schlüter C, Galle J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
8. Carey FA, Wallace WA, Fergusson RJ, Kerr KM, Lamb D (1992) Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax 47: 1041-1043
9. Costes V, Marty-Ane C, Picot MC, Serre I, Pujol JL, Mary H, Baldet P (1995) Typical an datypical bronchopulmonary carcinoid tumors: a clinicopathologic and Ki-67-labelIing study. Hum Pathol 26: 740-745
10. Dervan PA, Gilmartin LG, Loftus BM, Camey DN (1989) Breast carcinoma kinetics: argyrophilic nucleolar organizer region counts correlate with Ki67 scores. Am J Clin Pathol 92: 401-407
11. Fisseler-Eckhoff A, Becher T, Sudhoff H, Muller K-M (1994) AgNOR counts in preneoplastic lesions of the bronchus. Path Res Pract 190: 389-393
12. Fontanono G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A, Macchiarini P (1992) Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labelling and DB'NA flow cytometry. Am J Pathol 141: 1285-1290
13. Fraire AE, Greenberg SD (1973) Carcinoma and diffuse interstitial fibrosis of the lung. Cancer 31: 1078-1086
14. Gray SH, Cordonnier J (1929) Early cancer of the lung. Arch Surg 19: 1618-1626
15. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. Immunol 133: 161-162
16. Gerdes J, Stein H, Pileri S, Rivano MT, Gobbi M, Ralfkiaer E (1987) Prognostic relevance of tumor-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet II: 448-449
17. Gregory WM (1992) Cell proliferation and the principles of cancer therapy. In: Hall PA, Levison DA, Wright NA (eds) Assessment of cell proliferation in clinical practice. Springer, Berlin, pp 193-205
18. Grüne C (1993) Bronchiolo-alveoläre Tumorlets. Dissertationsschrift Med Fakultät der Bochum
19. Haddad R, Maasaro D (1968) Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med 44: 211-219
20. Hall PA, Richards MA, Gregory WM, d'Ardenne AL, Lister TA, Stansfield AG (1988) The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphomas. J Pathol 154: 223-235
21. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294
22. Hoffmann E (1962) Observaciones sobre la naturaleza y pathogenesis de los llamados "tumorlets" o proliferationes bronquiales atipicas. Rev Lat Amer Anat Path 6: 49-62
23. Jordan PA, Kerns BJ, Pence JC, Kohler MF, Bast RC, Kinney RB, Berchuck A (1993) Determination of proliferation Index in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 99: 736-740
24. Kay S (1958) Histologic and histogenetic observation on the peripheral adenoma of the lung. Am Med Assoc Arch Path 65: 395-402
25. Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Takagi K, Ogata T, Tamai S (1994) Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis. Cancer 74: 2468-2475
26. Kerr KM, Carey FA, Lamb D (1994) Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB 2 expression. J Pathol 174: 249-256
27. King LS (1954) Atypical proliferation of bronchiolar epithelium. Am Med Assoc Arch Path 58: 59-70
28. Kitamura H, Kameda Y, Nakamura N, Nakatani Y, Inayama Y, Iida M, Ogawa N, Shibagaki T, Kanisawa M (1995) Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am J Clin Pathol 146: 876-887
29. Kung ITM, Lui IOL, Loke SL, Khin MA, Mok CK, Lam KW, So SY (1985) Pulmonary scar cancer: a pathologic reappraisal. Am J Surg Pathol 9: 391-400
30. Madri JA, Carter D (1984) Scar cancers of the lung: origin and significance. Hum Pathol 15: 625-631
31. McCormick D, Hall PA (1992) The complexities of proliferating cell nuclear antigen. Histopathology 21: 591-594
32. Medsger TA Jr (1985) Systemic sclerosis and malignancy: are they related? J Rheumatol 12: 1041-1043
33. Meyer EC, Liebow AA (1965) Relationship of interstitial pneumonia, honey-combing and atypical epithelial proliferation to cancer of the lung. Cancer 18: 322-351
34. Mikail M, Sender B (1962) Nodular epithelial hyperplasia (tumorlets) of the lung. Am J Clin Pathol 37: 515-520
35. Miller RR, Nelems B, Evans KG, Muller NL, Ostrow DN (1988) Glandular neoplasia of the lung, a proposed analogy to colonic tumors. Cancer 61: 1009-1014
36. Monobe Y, Manabe T, Yamashita K (1994) Evaluation of atypical hyperplastic lesions of the lung by PCNA and AgNOR: comparison with hyperplastic lesions, adenoma arid adenocarcinoma. Jpn J Cancer 40: 568-574
37. Monobe Y, Manabe T (1995) Morphological changes and proliferative activity of alveolar epithelium in mouse lungs treated with urethan. Virch Arch 425: 583-588
38. Morkve O, Malvorson OJ, Stangeland L, Gulsvik A, Laerum OD (1992) Quantitation of biological tumor markers (p53, c-myc, Ki67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell tung cancer. Int J Cancer 52: 851-855
39. Müller K-M, Menne R, Hüther W, Gröbe H (1979) Fatal pneumopathy after cytostatic treatment for leukemia in children. J Cancer Res Clin Oncol 94: 287-294
40. Müller K-M, Fisseler-Eckhoff A, Reitemeyer E (1988) Stromareaktion in Lungentumoren. Tumorvernarbung und sog. Narbencarcinom. Fortschr Med 106: 19-23
41. Müller K-M (1988) Early cancer of the lung. Rec Res Cancer Res 106: 119-130
42. O'Reilly SM, Richards MA (1992) Clinical aspects of assessing cell proliferation. In: Hall PA, Levison DA, Wright NA (eds) Assessment of cell proliferation in clinical practice. Springer, Berlin, pp 177-191
43. Pence JC, Kerns BJ, Dodge RK, Iglehart JD (1993) Prognostic significance of proliferation index in surgically resected non-small cell lung cancer. Arch Surg 128: 1382-1390
44. Roumm AD, Medsger Ta Jr (1985) Cancer and systemic sclerosis: an epidemiologic Study. Arthritis Rheum 28: 1336-1349
45. Scagliotti GV, Micela M, Gubetta L, Leonardo E, Cappia S, Borasio P, Pozzi E (1993) Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 28A: 363-365
46. Shivij KK, Kenny MK, Wood RD (1992) Proliferating cell nuclear antigen (PCNA) is required for DNA excision repair. Cell 69: 2367-2374
47. Soomro IN, Whimster WF (1990) Growth fraction in lung tumors determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol 162: 217-222
48. Spencer H, Raeburn C (1954) Atypical proliferation of bronchiolar epithelium. J Path Bact 67: 187-193
49. Stanford RE (1988) Connective tissue disease. In: Dail DH, Hammar S (eds) Pulmonary pathology. Springer, Berlin Heidelberg New York
50. Tungekar MF, Gatter KC, Dunnill MS, Mason DY (1991) Ki-67 immunostaining and survival in operable lung cancer. Histopathology 19: 545-550
51. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A (1980) Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35: 496-499
52. Yoshida Y (1994) A correlation between mutation of the p53 gene and histological heterogeneity in differentiated adenocarcinomas of the lung, with reference to stepwise progression and metastatic ability. Hiroshima J Med Sci 43: 13-21
53. Wells M, Brown LJR (1986) Glandular lesions of the cervix uteri. The present state of our knowledge. Histopathology 10: 777-792
54. Whitwell F (1955) Tumorlets of the lung. J Pathol 70: 529-541
55. World Health Organisation (1982) The WHO histological typing of lung tumors. Am J Clin Pathol 77: 123-136